Literature DB >> 3131289

Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. I. Screening of antibiotics-producing myxobacteria and production of megovalicins.

S Miyashiro1, S Yamanaka, S Takayama, H Shibai.   

Abstract

New antibiotics belonging to macrocyclic were discovered and named megovalicins A, B, C, D, G and H. The antibiotics were accumulated endogeneously by a newly isolated myxobacterium identified as Myxococcus flavescens. Tank culture of the bacterium for 4 days gave 8.8 g cells/liter on a wet basis, and 4.8, 7.1, 20.0, 0.4, 3.75 and 15.0 micrograms of megovalicins A, B, C, D, G and H respectively were obtained from 1 g wet cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131289     DOI: 10.7164/antibiotics.41.433

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  PCR detection of type I polyketide synthase genes in myxobacteria.

Authors:  Hisayuki Komaki; Ryosuke Fudou; Takashi Iizuka; Daisuke Nakajima; Koei Okazaki; Daisuke Shibata; Makoto Ojika; Shigeaki Harayama
Journal:  Appl Environ Microbiol       Date:  2008-07-07       Impact factor: 4.792

2.  Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.

Authors:  Yao Xiao; Klaus Gerth; Rolf Müller; Daniel Wall
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.